Autophagy-enhancing strategies to promote intestinal viral resistance and mucosal barrier function in SARS-CoV-2 infection

Autophagy-enhancing strategies to promote intestinal viral resistance and mucosal barrier function in SARS-CoV-2 infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease 19 (COVID-19), continues to circulate globally despite the widespread vaccination and therapeutics like Paxlovid, remdesivir, and molnupiravir. COVID-19 is associated with both respiratory and ga...

Full description

Saved in:
Bibliographic Details
Main Authors: Anusca G. Rader, Alexandra P.M. Cloherty, Kharishma S. Patel, Dima D.A. Almandawi, Jimena Perez-Vargas, Manon E. Wildenberg, Vanesa Muncan, Renée R.C.E. Schreurs, François Jean, Carla M.S. Ribeiro
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Autophagy Reports
Subjects:
Antiviral immunity
autophagy
epithelial cells
human intestinal organoids
host-directed therapy
SARS-CoV-2
Online Access:https://www.tandfonline.com/doi/10.1080/27694127.2025.2514232
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items